These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gonadotropin-induced expression of receptors for growth hormone releasing factor in cultured granulosa cells. Bagnato A, Moretti C, Frajese G, Catt KJ. Endocrinology; 1991 Jun; 128(6):2889-94. PubMed ID: 1674686 [Abstract] [Full Text] [Related]
3. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat. Laburthe M, Couvineau A, Rouyer-Fessard C. Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561 [Abstract] [Full Text] [Related]
4. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function. Ciampani T, Fabbri A, Isidori A, Dufau ML. Endocrinology; 1992 Dec; 131(6):2785-92. PubMed ID: 1332849 [Abstract] [Full Text] [Related]
5. Growth hormone releasing factor and vasoactive intestinal peptide stimulate rat granulosa cell plasminogen activator activity in vitro during follicular development. Karakji EG, Tsang BK. Mol Cell Endocrinol; 1995 Jan; 107(1):105-12. PubMed ID: 7796929 [Abstract] [Full Text] [Related]
6. Vasoactive intestinal peptide: a novel stimulator of steroidogenesis by cultured rat granulosa cells. Davoren JB, Hsueh AJ. Biol Reprod; 1985 Aug; 33(1):37-52. PubMed ID: 2998497 [Abstract] [Full Text] [Related]
10. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Westendorf JM, Schonbrunn A. Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986 [Abstract] [Full Text] [Related]
11. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Waelbroeck M, Robberecht P, Coy DH, Camus JC, De Neef P, Christophe J. Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987 [Abstract] [Full Text] [Related]